Invetx

Acquired

Biotech built for pets

Boston, United States · Founded 2018

Employees
11–50
Founded
2018
Business Model
B2B
Website
invetx.com
Last Round
Series BMay 2022
Rounds
3

Indexed holds 3 funding rounds and 6 investors for this company. The full record is or through the API.

About

Founded in 2018 and headquartered in Boston, Massachusetts, Invetx is a biopharmaceutical company building the world's premier animal health biotechnology platform. By leveraging validated protein-engineering technologies from human biopharma and optimizing them for veterinary application, Invetx develops novel, differentiated protein-based therapeutics to treat chronic and serious diseases in companion animals including dogs and cats. The company partners with leading biotech firms to generate best-in-class antibodies across a wide range of targets, aiming to transform standards of care in veterinary medicine. Invetx was acquired by Dechra Pharmaceuticals.

Summary

Invetx is a Biotech company based in Boston, United States, founded in 2018. Its most recent funding was a Series B round in May 2022. Investors include F-Prime Capital, GV and Eight Roads Ventures.

Tech & App Stack

7 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding History

Series BSeries BMay 2022

Sign up to see all 3 events

Funding: Seed through Series B. Amounts, valuations, and investors where available.

Investors

Similar Companies

Tiantan Biological / China Biologic (泰邦生物集团)

China's leading blood products manufacturer

Beijing, China1001–5000Biotech, Healthcare
Growth EquityTotal funding$5.1BAug 2022
Pharmaceutical Product Development, Inc. (PPD)Acquired

Global contract research organization providing comprehensive drug development and laboratory ser...

Wilmington, United States10001+Biotech, Healthcare
Private EquityTotal funding$3.9BJan 2019
Warner ChilcottAcquired

Specialty pharmaceutical company

Rockaway, United States1001–5000Biotech, Healthcare
Private EquityTotal funding$3.0BJan 2004
Altos Labs

Altos Labs combines academic science and industry development to create medicines that restore ce...

San Francisco, United States501–1000Life Sciences, Biotech
Series ATotal funding$3.0BJan 2022
Syneos HealthAcquired

Integrated biopharmaceutical solutions company

Burlington, United States10001+Biotech, Healthcare
Private EquityTotal funding$3.0BMay 2017
BeiGeneIPO

BeOne Medicines develops transformative oncology medicines through rigorous science, an accelerat...

Cambridge, United States10001+Biotech, Oncology
Corporate RoundTotal funding$2.8BJan 2020

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

Invetx on Indexed.vc
<a href="https://indexed.vc/companies/invetx"><img src="https://indexed.vc/api/badge/company/invetx" alt="Invetx on Indexed.vc" width="260" height="76" /></a>